BJL
ALNY icon

Brighton Jones LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

Brighton Jones LLC’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
4,898
-801
-14% -$242K 0.03% 395
2026
Q1 		$1.89M Buy
+5,699
New +$1.94M 0.04% 280
2025
Q4 		– Sell
-4,941
Closed -$2.25M – 91
2025
Q3 		$2.25M Buy
4,941
+3,909
+379% +$1.59M 0.05% 203
2025
Q2 		$336K Sell
1,032
-177
-15% -$49K 0.01% 673
2025
Q1 		$326K Buy
1,209
+177
+17% +$45.5K 0.01% 509
2024
Q4 		$243K Buy
+1,032
New +$271K 0.01% 590
2023
Q4 		– Sell
-3,912
Closed -$693K – 584
2023
Q3 		$693K Buy
3,912
+136
+4% +$25.9K 0.04% 230
2023
Q2 		$717K Buy
3,776
+23
+0.6% +$4.56K 0.04% 239
2023
Q1 		$752K Buy
+3,753
New +$789K 0.04% 218
2018
Q3 		– Sell
-3,957
Closed -$390K – 284
2018
Q2 		$390K Sell
3,957
-47
-1% -$4.66K 0.05% 200
2018
Q1 		$477K Sell
4,004
-18
-0.4% -$2.32K 0.07% 162
2017
Q4 		$511K Buy
4,022
+11
+0.3% +$1.38K 0.06% 149
2017
Q3 		$471K Hold
4,011
– – 0.06% 159
2017
Q2 		$320K Buy
+4,011
New +$256K 0.05% 189
2016
Q4 		– Sell
-3,919
Closed -$266K – 107
2016
Q3 		$266K Buy
+3,919
New +$276K 0.04% 194

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brighton Jones LLC's ALNY Position: Q2 2026 in Review

Brighton Jones LLC reduced its Alnylam Pharmaceuticals (ALNY) stake by 14% in Q2 2026, selling an estimated $242K and leaving 4,898 shares worth $1.47M. The position accounts for 0.03% of the portfolio, ranked #395.

Brighton Jones LLC first reported a position in ALNY in Q3 2016 and has held it in 15 quarters since. The position peaked at $2.25M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Brighton Jones LLC held 4,898 shares of Alnylam Pharmaceuticals worth $1.47M as of Q2 2026.
  • Brighton Jones LLC sold 801 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $242K.
  • Alnylam Pharmaceuticals made up 0.03% of Brighton Jones LLC's portfolio in Q2 2026, its #395 holding.
  • Brighton Jones LLC first reported a position in Alnylam Pharmaceuticals in Q3 2016 and has held it in 15 quarters since.
  • Brighton Jones LLC's Alnylam Pharmaceuticals position peaked at $2.25M in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.